2020 Documentaries · Episode 33
The power of pharmaceutical companies
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices? A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.
Community
–
No ratings 0 likes
Log in to rate episodes.
Episode reviews
No reviews for this episode yet.